iShares NASDAQ US Biotechnology UCITS ETF USD (Acc)

The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund's assets, which reflects the return of the NASDAQ Biotechnology Index, the Fund's benchmark index (Index). The Share Class, via the Fund is passively managed, and aims to invest so far as possible and practicable in the equity securities (e.g. shares) that make up the Index. The Index measures the performance of companies listed on the NASDAQ Stock Market that are classified as either biotechnology companies or pharmaceutical companies, according to their Industry Classification Benchmark (ICB) and that also meet other eligibility criteria as determined by NASDAQ, Inc. (the Index Provider), including minimum market capitalisation and liquidity requirements. Market capitalisation is the share price of the company multiplied by the number of shares issued. Securities that are liquid means that they can be easily bought or sold in the market in normal market conditions. The Index is weighted by a modified market capitalisation methodology, as determined by the Index Provider, such that the maximum weight of any Index constituent is capped at 8% and no more than five securities are at that cap. The excess weight of any capped security is distributed proportionally across the remaining constituent securities in the Index. This process is repeated, if necessary, to derive the final weights. The Fund intends to replicate the Index by holding the equity securities which make up the Index, in similar proportions to it. The Fund may also engage in short-term secured lending of its investments to certain eligible third parties to generate additional income to off-set the costs of the Fund. The investment manager may use financial derivative instruments (FDIs) (i.e. investments the prices of which are based on one or more underlying assets) to help achieve the Fund's investment objective. The price of equity securities fluc

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No